AlloVir
About:
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Website: https://www.allovir.com
Top Investors: Fidelity, Invus, Samsara BioCapital, Gilead Sciences, ElevateBio
Description:
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases. It provides an ideal environment for ViraCyte to develop and advance its product pipeline from discovery through late-stage clinical trials.
$361M
$1M to $10M
Houston, Texas, United States
2013-01-01
info(AT)viracyte.com
Ann Leen, John Wilson
101-250
2023-06-21
Public
© 2025 bioDAO.ai